Literature DB >> 17085102

Primary carcinoid tumors of the kidney.

Frederico R Romero1, Soroush Rais-Bahrami, Sompol Permpongkosol, Samson W Fine, Sahar Kohanim, Thomas W Jarrett.   

Abstract

PURPOSE: We describe in detail the features of carcinoid tumors of the kidney. We evaluated possible prognostic factors.
MATERIALS AND METHODS: An extensive search was performed in the medical literature regarding primary carcinoid tumors of the kidney. Epidemiological, clinical, diagnostic, histopathological, therapeutic and prognostic data were evaluated. Several potential risk factors were compared with the incidence of metastases and clinical outcome of the patients.
RESULTS: A total of 56 case reports were reviewed. Median patient age was 49 years. Horseshoe kidneys were present in 17.8% of cases. Incidental diagnosis was made in 28.6% of patients. The most common symptom was abdominal or flank pain and neuroendocrine syndromes occurred with only 12.7% of primary renal carcinoid tumors. Of the patients 73.6% presented with tumors larger than 4 cm. Metastases were present in 45.6% of patients at initial diagnosis and almost 60% with tumors greater than 4 cm had metastases.
CONCLUSIONS: Renal carcinoid is the second most prevalent genitourinary carcinoid in each sex, following testicular carcinoids in men and ovarian tumors in women. Significant adverse prognostic factors include age greater than 40 years, tumor size greater than 4 cm, purely solid tumors on the cut surface, mitotic rate higher than 1/10 high power fields, metastasis at initial diagnosis and tumors extending throughout the renal capsule.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17085102     DOI: 10.1016/j.juro.2006.07.129

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  42 in total

1.  [Primary neuroendocrine tumor of the kidney. A rarity].

Authors:  P Maletzki; P A Diener; D Bjasch; H-P Schmid; T Gramann
Journal:  Urologe A       Date:  2015-06       Impact factor: 0.639

2.  Primary carcinoid tumor of the kidney with estrogen and progesterone receptor expression.

Authors:  Chunhua Lin; Jitao Wu; Zhenli Gao; Guimei Qu; Wei Wang; Guohua Yu
Journal:  Oncol Lett       Date:  2015-04-30       Impact factor: 2.967

3.  Primary renal large cell neuroendocrine carcinoma in a young man.

Authors:  Cornerstone Wann; Nirmal Thampi John; Ramani Manoj Kumar
Journal:  J Clin Diagn Res       Date:  2014-11-20

4.  Primary Renal Carcinoid Tumor: Report of Two Cases.

Authors:  Ramzi Jabaji; Tyler Kern; Dejun Shen; William Chu; Madhur Merchant
Journal:  Perm J       Date:  2020-03-13

5.  Five New Cases of Primary Renal Carcinoid Tumor: Case Reports and Literature Review.

Authors:  Joel E Rosenberg; Jacob A Albersheim; Niranjan J Sathianathen; Paari Murugan; Christopher J Weight
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

6.  Primary renal carcinoid tumour with lung metastasis misdiagnosed as renal cell carcinoma.

Authors:  Nour Daboul; Dulabh Monga; Mark Bunker
Journal:  BMJ Case Rep       Date:  2016-03-07

7.  Renal neuroendocrine tumors.

Authors:  Brian R Lane; George Jour; Ming Zhou
Journal:  Indian J Urol       Date:  2009-04

8.  Invasive neuroendocrine tumor of the kidney: a case report.

Authors:  Ephrem O Olweny; Michael H Hsieh; Jill C Buckley; Jack W McAninch
Journal:  Rare Tumors       Date:  2009-12-28

9.  Renal carcinoid tumor: An immunohistochemical and molecular genetic study of four cases.

Authors:  Naoto Kuroda; Isabel Alvarado-Cabrero; Radek Sima; Ondrej Hes; Michal Michal; Hidefumi Kinoshita; Tadashi Matsuda; Chisato Ohe; Noriko Sakaida; Yoshiko Uemura; Gang-Hong Lee
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

10.  Synchronous primary carcinoid tumor and primary adenocarcinoma arising within mature cystic teratoma of horseshoe kidney: a unique case report and review of the literature.

Authors:  Henry B Armah; Anil V Parwani; Aleksandr M Perepletchikov
Journal:  Diagn Pathol       Date:  2009-06-14       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.